Literature DB >> 9486299

Defense of differing body weight set points in diet-induced obese and resistant rats.

B E Levin1, R E Keesey.   

Abstract

Among outbred Sprague-Dawley rats, approximately one-half develop diet-induced obesity (DIO) and one-half are diet resistant (DR) on a diet relatively high in fat and energy content (HE diet). Here we examined the defense of body weight in these two phenotypes. After HE diet for 13 wk, followed by chow for 6 wk, DR rats gained weight comparably but their plasma leptin levels fell to 54% of chow-fed controls. When a palatable liquid diet (Ensure) was added for 13 wk, other DR rats became obese. But when switched to chow, their intakes fell by 60%, and body and retroperitoneal (RP) fat pad weights and plasma leptin and insulin levels all declined for 2 wk and then stabilized at control levels after 6 wk. In contrast, comparably obese DIO rats decreased their intake by only 20%, and their weights plateaued when they were switched to chow after 13 wk on HE diet. When a subgroup of these DIO rats was restricted to 60% of prior intake, their weights fell to chow-fed control levels over 2 wk. But their leptin and insulin levels both fell disproportionately to 30% of controls. When no longer restricted, their intake and feed efficiency rose immediately, and their body and RP pad weights and leptin and insulin levels rose to those of unrestricted DIO rats within 2 wk. Thus diet and genetic background interact to establish high (DIO) or low (DR) body weight set points, which are then defended against subsequent changes in diet composition and/or energy availability. If leptin affects energy homeostasis, it does so differentially in DIO vs. DR rats since comparably low and high levels were associated with differing patterns of weight change between the two phenotypes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486299     DOI: 10.1152/ajpregu.1998.274.2.R412

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  74 in total

Review 1.  Laboratory animals as surrogate models of human obesity.

Authors:  Cecilia Nilsson; Kirsten Raun; Fei-fei Yan; Marianne O Larsen; Mads Tang-Christensen
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

2.  Energy expenditure in obesity-prone and obesity-resistant rats before and after the introduction of a high-fat diet.

Authors:  Matthew R Jackman; Paul S MacLean; Daniel H Bessesen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-08-04       Impact factor: 3.619

3.  Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats.

Authors:  Gitte Hansen; Jacob Jelsing; Niels Vrang
Journal:  Acta Pharmacol Sin       Date:  2012-02       Impact factor: 6.150

4.  Reduced accumbens dopamine in Sprague-Dawley rats prone to overeating a fat-rich diet.

Authors:  Pedro Rada; Miriam E Bocarsly; Jessica R Barson; Bartley G Hoebel; Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2010-07-16

Review 5.  Relevance of animal models to human eating disorders and obesity.

Authors:  Regina C Casper; Elinor L Sullivan; Laurence Tecott
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

Review 6.  Trafficking of dietary fat and resistance to obesity.

Authors:  Daniel H Bessesen; Sarah Bull; Marc A Cornier
Journal:  Physiol Behav       Date:  2008-04-22

Review 7.  Reconceptualizing anorexia nervosa.

Authors:  Cynthia M Bulik; Rachael Flatt; Afrouz Abbaspour; Ian Carroll
Journal:  Psychiatry Clin Neurosci       Date:  2019-07-01       Impact factor: 5.188

8.  Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli.

Authors:  Michael Rosenbaum; Melissa Sy; Katherine Pavlovich; Rudolph L Leibel; Joy Hirsch
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

9.  LAP-BAND for BMI 30-40: 5-year health outcomes from the multicenter pivotal study.

Authors:  J B Dixon; L L Eaton; V Vincent; R Michaelson
Journal:  Int J Obes (Lond)       Date:  2015-08-18       Impact factor: 5.095

10.  Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity.

Authors:  Lisa M Davis; Michael Michaelides; Lawrence J Cheskin; Timothy H Moran; Susan Aja; Paul A Watkins; Zhengtong Pei; Carlo Contoreggi; Karen McCullough; Bruce Hope; Gene Jack Wang; Nora D Volkow; Panayotis K Thanos
Journal:  Neuroendocrinology       Date:  2008-11-04       Impact factor: 4.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.